Autoimmunity and tumor immunology: two facets of a probabilistic immune system.
BACKGROUND
The immune system of vertebrates has evolved the ability to mount highly elaborate responses to a broad range of pathogen-driven threats. Accordingly, it is quite a challenge to understand how a primitive adaptive immune system that probably lacked much of its present complexity could provide its bearers with significant evolutionary advantage, and therefore, continue to be selected for.


RESULTS
We have developed a very simple model of the immune system that captures the probabilistic communication between its innate and adaptive components. Probabilistic communication arises specifically from the fact that antigen presenting cells collect and present a range of antigens from which the adaptive immune system must (probabilistically) identify its target. Our results show that although some degree of self-reactivity in the immune repertoire is unavoidable, the system is generally able to correctly target pathogens rather than self-antigens. Particular circumstances that impair correct targeting and that may lead to infection-induced autoimmunity can be predicted within this framework. Notably, the probabilistic immune system exhibits the remarkable ability to detect sudden increases in the abundance of rare self-antigens, which represents a first step towards developing anti-tumoral responses.


CONCLUSIONS
A simple probabilistic model of the communication between the innate and adaptive immune system provides a robust immune response, including targeting tumors, but at the price of being at risk of developing autoimmunity.
Centro de Astrobiología, INTA - CSIC, Madrid, Spain. iranzosj@cab.inta-csic.es.|Current address: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA. iranzosj@cab.inta-csic.es.
Jaime
J
Iranzo
Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Casanova 145, Cellex Center 3A, 08036, Barcelona, Spain. pvilloslada@clinic.ub.es.
Pablo
P
Villoslada
D056704:Adaptive Immunity / Q000276:immunology*; D000818:Animals; D015551:Autoimmunity / Q000276:immunology*; D005075:Biological Evolution; D007113:Immunity, Innate / Q000276:immunology*; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology*; D011336:Probability; D013045:Species Specificity; D014714:Vertebrates / Q000276:immunology*